Aeterna Zentaris (AEZS)

P/S ratio as of November 2024 (TTM): 2.77

According to Aeterna Zentaris's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.6677. At the end of 2024 the company had a P/S ratio of 2.11.

P/S ratio history for Aeterna Zentaris from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	2.11	26.91%
2023	1.67	20.62%
2022	1.38	-65.6%
2021	4.01	29.92%
2020	3.09	26.81%
2019	2.44	-68.13%
2018	7.64	52.89%
2017	5.00	-6.33%
2016	5.34	-27.5%
2015	7.36	32.8%
2014	5.54	-47.56%
2013	10.6	-10.13%
2012	11.8	-56.49%
2011	27.0	2.55%
2010	26.4	73.79%
2009	15.2	96.21%
2008	7.73	-70.77%
2007	26.4	-69.71%
2006	87.3	-39.16%
2005	143	-38.4%
2004	233	90.46%
2003	122	-49.2%
2002	241	-42.98%
2001	422

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Spectrum Pharmaceuticals SPPI	8.22	196.42%	🇺🇸 USA
Novartis NVS	4.16	49.99%	🇨🇭 Switzerland
Bristol-Myers Squibb BMY	2.49	-10.18%	🇺🇸 USA
Sanofi SNY	2.27	-17.98%	🇫🇷 France
Halozyme Therapeutics HALO	6.14	121.41%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Aeterna Zentaris (AEZS)

P/S ratio as of November 2024 (TTM): 2.77